Wird geladen...
Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
Evidence about the treatment of hospitalized type 2 diabetes patients with incretin‐based therapy has emerged in the past 15 years. Based on this evidence, dipeptidyl peptidase‐4 inhibitors should be considered for hospitalized patients with type 2 diabetes and an algorithm for this is proposed. In...
Gespeichert in:
| Veröffentlicht in: | J Diabetes Investig |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078129/ https://ncbi.nlm.nih.gov/pubmed/31529777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13130 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|